Lineage Cell Therapeutics Inc. (LCTX) stock shows an incline. Why?
Lineage Cell Therapeutics, Inc. (LCTX), a clinical-stage biotechnology company specializing to develop allogeneic cell therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and assisting the body in detecting and fighting cancer, reported financial and operating report for the first quarter of 2021. At last check in premarket trading, the share price of Lineage […]